- Home
- NAMS vs BGM Comparison
NAMS vs BGM Comparison
Compare NAMS & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- BGM
- Stock Information
- Founded
- NAMS 2019
- BGM 2019
- Country
- NAMS Netherlands
- BGM China
- Employees
- NAMS N/A
- BGM N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- NAMS Health Care
- BGM
- Exchange
- NAMS Nasdaq
- BGM NYSE
- Market Cap
- NAMS 2.5B
- BGM 2.6B
- IPO Year
- NAMS N/A
- BGM 2021
- Fundamental
- Price
- NAMS $19.85
- BGM $10.03
- Analyst Decision
- NAMS Strong Buy
- BGM
- Analyst Count
- NAMS 8
- BGM 0
- Target Price
- NAMS $42.88
- BGM N/A
- AVG Volume (30 Days)
- NAMS 1.0M
- BGM 107.5K
- Earning Date
- NAMS 08-06-2025
- BGM 08-13-2025
- Dividend Yield
- NAMS N/A
- BGM N/A
- EPS Growth
- NAMS N/A
- BGM N/A
- EPS
- NAMS N/A
- BGM N/A
- Revenue
- NAMS $47,140,000.00
- BGM $25,097,951.00
- Revenue This Year
- NAMS N/A
- BGM N/A
- Revenue Next Year
- NAMS N/A
- BGM N/A
- P/E Ratio
- NAMS N/A
- BGM N/A
- Revenue Growth
- NAMS 586.97
- BGM N/A
- 52 Week Low
- NAMS $14.06
- BGM $5.26
- 52 Week High
- NAMS $27.29
- BGM $17.17
- Technical
- Relative Strength Index (RSI)
- NAMS 52.90
- BGM 35.45
- Support Level
- NAMS $17.97
- BGM $9.58
- Resistance Level
- NAMS $19.13
- BGM $13.71
- Average True Range (ATR)
- NAMS 1.04
- BGM 1.29
- MACD
- NAMS -0.03
- BGM -0.49
- Stochastic Oscillator
- NAMS 35.63
- BGM 7.56
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.